Yuri van der Heijden, M.D.

Assistant Professor

yuri.vanderheijden@vanderbilt.edu
Faculty Appointments
Assistant Professor of Medicine
Education
M.P.H., Public Health, Vanderbilt University, Nashville, TennesseeM.D., Medicine, Vanderbilt University, Nashville, TennesseeB.S., Furman University, Greenville, South Carolina
Publications
van der Heijden YF, Karim F, Mufamadi G, Zako L, Chinappa T, Shepherd BE, Maruri F, Moosa MS, Sterling TR, Pym AS. Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa. Int. J. Tuberc. Lung Dis. 2017 Jun 6/1/2017; 21(6): 670-6. PMID: 28482962, DOI: 10.5588/ijtld.16.0843, ISSN: 1815-7920.

Eilertson B, Maruri F, Blackman A, Guo Y, Herrera M, van der Heijden Y, Shyr Y, Sterling TR. A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother [print-electronic]. 2016 Sep; 71(9): 2419-27. PMID: 27261264, PMCID: PMC4992850, PII: dkw168, DOI: 10.1093/jac/dkw168, ISSN: 1460-2091.

van der Heijden YF, Heerman WJ, McFadden S, Zhu Y, Patterson BL. Missed opportunities for tuberculosis screening in primary care. J. Pediatr [print-electronic]. 2015 May; 166(5): 1240-1245.e1. PMID: 25720366, PMCID: PMC4414729, PII: S0022-3476(15)00084-0, DOI: 10.1016/j.jpeds.2015.01.037, ISSN: 1097-6833.

Van Der Heijden YF, Maruri F, Holt E, Mitchel E, Warkentin J, Sterling TR. A comparison of interview methods to ascertain fluoroquinolone exposure before tuberculosis diagnosis. Epidemiol. Infect [print-electronic]. 2015 Apr; 143(5): 960-5. PMID: 25420688, PMCID: PMC4352378, PII: S0950268814003136, DOI: 10.1017/S0950268814003136, ISSN: 1469-4409.

van der Heijden YF, Maruri F, Blackman A, Mitchel E, Bian A, Shintani AK, Eden S, Warkentin JV, Sterling TR. Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones. Int. J. Antimicrob. Agents [print-electronic]. 2013 Sep; 42(3): 232-7. PMID: 23806638, PMCID: PMC3780576, PII: S0924-8579(13)00185-4, DOI: 10.1016/j.ijantimicag.2013.04.027, ISSN: 1872-7913.

van der Heijden YF, Maruri F, Blackman A, Holt E, Warkentin JV, Shepherd BE, Sterling TR. Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death. Int. J. Tuberc. Lung Dis [print-electronic]. 2012 Sep; 16(9): 1162-7. PMID: 22794509, PMCID: PMC3981533, PII: ijtld120046, DOI: 10.5588/ijtld.12.0046, ISSN: 1815-7920.

Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J. Antimicrob. Chemother [print-electronic]. 2012 Apr; 67(4): 819-31. PMID: 22279180, PMCID: PMC3299416, PII: dkr566, DOI: 10.1093/jac/dkr566, ISSN: 1460-2091.

van der Heijden YF, Miller G, Wright PW, Shepherd BE, Daniels TL, Talbot TR. Clinical impact of blood cultures contaminated with coagulase-negative staphylococci at an academic medical center. Infect Control Hosp Epidemiol. 2011 Jun; 32(6): 623-5. PMID: 21558778, DOI: 10.1086/660096, ISSN: 1559-6834.